LEXINGTON, Mass., May 22, 2012 /PRNewswire/ -- Avaxia Biologics, Inc., a privately-held biotechnology company developing oral antibody drugs that act locally within the gastrointestinal tract,

PRINCETON, N.J., Feb. 21, 2012 /PRNewswire/ -- Soligenix, Inc.

PRINCETON, N.J., Feb. 10, 2012 /PRNewswire/ -- Soligenix, Inc.

A combination of two drugs may alleviate radiation sickness in people who have been exposed to high levels of radiation, even when the therapy is given a day after the exposure occurred.

PRINCETON, N.J., June 27, 2011 /PRNewswire/ -- Soligenix, Inc.